(Q44542016)

English

Effects of FK506 and rapamycin on generation of reactive oxygen species, nitric oxide production and nuclear factor kappa B activation in rat hepatocytes

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Effects of FK506 and rapamycin on generation of reactive oxygen species, nitric oxide production and nuclear factor kappa B activation in rat hepatocytes (English)

1 reference

Europe PubMed Central

4 December 2017

reactive oxygen species

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

María J. Tuñón

1

1 reference

Europe PubMed Central

4 December 2017

Sonia Sánchez-Campos

2

1 reference

Europe PubMed Central

4 December 2017

Javier González-Gallego

5

1 reference

Europe PubMed Central

4 December 2017

author name string

Belén Gutiérrez

3

1 reference

Europe PubMed Central

4 December 2017

Jesús M Culebras

4

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

4 December 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

4 December 2017

66

1 reference

Europe PubMed Central

4 December 2017

3

1 reference

Europe PubMed Central

4 December 2017

439-445

1 reference

Europe PubMed Central

4 December 2017

Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

A mammalian protein targeted by G1-arresting rapamycin-receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Cyclosporin A, FK506 and rapamycin: more than just immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-kappaB dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Reactive oxygen species, cell signaling, and cell injury

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Biology of nitric oxide signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Immunosuppressant FK506 activates NF-kappaB through the proteasome-mediated degradation of IkappaBalpha. Requirement for Ikappabalpha n-terminal phosphorylation but not ubiquitination sites

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

CHOLESTASIS AND ALTERATIONS OF GLUTATHIONE METABOLISM INDUCED BY TACROLIMUS (FK506) IN THE RAT1

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Effects of aging on the susceptibility to the toxic effects of cyclosporin A in rats. Changes in liver glutathione and antioxidant enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Tacrolimus decreases in vitro oxidative phosphorylation of mitochondria from rat forebrain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Immunosuppressive and non-immunosuppressive immunophilin ligands improve H(2)O(2)-induced cell damage by increasing glutathione levels in NG108-15 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Macrophage-induced inhibition of nitric oxide production in primary rat hepatocyte cultures via prostaglandin E2 release

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

IkappaB kinase: beginning, not the end

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Is NF-kappaB the sensor of oxidative stress?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900288-0

7 January 2021

Identifiers

10.1016/S0006-2952(03)00288-0

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44542016&oldid=2027231821"